Bcann

Better, widely known by its brand name Bcann, is a pioneering Israeli medical cannabis company dedicated to the research, cultivation, and clinical application of cannabinoid-based therapies. Established in 2008, the company focuses on developing standardized, strain-specific medical cannabis products for complex conditions including refractory epilepsy, autism, and chronic pain. Better is recognized for its rigorous clinical research, including significant studies on pediatric epilepsy and gastrointestinal disorders conducted in collaboration with major medical centers. The company operates advanced cultivation and manufacturing facilities to produce pharmaceutical-grade oils and inflorescences. Their mission centers on providing evidence-based cannabis solutions to improve patient quality of life globally through proprietary genetics and standardized production methods.